Evidence map›Paper›PMID 38044276›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Traditional Chinese Medicine Formulae QY305 Reducing Cutaneous Adverse Reaction and Diarrhea by its Nanostructure.

Ya-Li Zhang, Ya-Lei Wang, Ke Yan, Haiyan Li, Xinyu Zhang, Julien Milon Essola, Chengcheng Ding, Kexin Chang, Guangchao Qing, Fuxue Zhang and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ya-Li ZhangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Ya-Lei WangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Ke YanSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Haiyan LiSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xinyu ZhangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Julien Milon EssolaCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China.
Chengcheng DingSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Kexin ChangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Guangchao QingCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China.
Fuxue ZhangCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China.
Yan TanSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Tiantian PengSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xu WangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Miao JiangSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xing-Jie LiangCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences and National Center for Nanoscience and Technology of China, Beijing, 100190, China.ORCID 0000-0002-4793-1705
Qian HuaSchool of Life Sciences, School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.ORCID 0000-0003-4238-4594

Funding

Chinese Academy of Sciences (CAS-NSTDA) International Partnership Program 121D11KYSB20210003National Key Research and Development Program of China 2021YFA1201000NSFC international collaboration key project 51861135103NSFC key project 32030060NSFC regional innovation and development joint fund U21A20414
6 · The paper itself

Abstract

Traditional Chinese medicine (TCM) is widely used in clinical practice, including skin and gastrointestinal diseases. Here, a potential TCM QY305 (T-QY305) is reported that can modulate the recruitment of neutrophil in skin and colon tissue thus reducing cutaneous adverse reaction and diarrhea induced by epidermal growth factor receptor inhibitors (EGFRIs). On another hand, the T-QY305 formula, through regulating neutrophil recruitment features would highlight the presence of N-QY305, a subunit nanostructure contained in T-QY305, and confirm its role as potentially being the biomaterial conferring to T-QY305 its pharmacodynamic features. Here, the clinical records of two patients are analyzed expressing cutaneous adverse reaction and demonstrate positive effect of T-QY305 on the simultaneous inhibition of both cutaneous adverse reaction and diarrhea in animal models. The satisfying results obtained from T-QY305, lead to further process to the isolation of N-QY305 from T-QY305, in order to demonstrate that the potency of T-QY305 originates from the nanostructure N-QY305. Compared to T-QY305, N-QY305 exhibits higher potency upon reducing adverse reactions. The data represent a promising candidate for reducing cutaneous adverse reaction and diarrhea, meanwhile proposing a new strategy to highlight the presence of nanostructures being the "King" of Chinese medicine formula as the pharmacodynamic basis.

Indexed as

Drugs, Chinese HerbalMedicine, Chinese TraditionalAnimalsDiarrheaHumansDrugs, Chinese Herbalcutaneous adverse reaction and diarrheananostructurepharmacodynamic basisQY305traditional Chinese medicine

Identifiers

PMID38044276
PMCPMC10837375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.